Germany HIV Market and Competitive Landscape Highlights – 2016

Germany HIV Market and Competitive Landscape Highlights – 2016

  • April 2016 •
  • Report ID: 3893521 •
  • Format: PDF
The latest research from Fore Pharma, Germany HIV Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into HIV pipeline products, HIV epidemiology, HIV market valuations and forecast, HIV products sales and competitive landscape in Germany.

The research is classified into nine sections – HIV overview including etiology, pathophysiology, and diagnosis, HIV treatment options, HIV pipeline products, HIV market analysis comprising of HIV epidemiology, key products marketed for HIV, market valuations and forecast, products sales and market shares.

Research Scope:
- HIV Pipeline: Find out the products in clinical trials for the treatment of HIV by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
- HIV Epidemiology: Find out the number of patients diagnosed (prevalence) with HIV in Germany
- HIV Products: Identify key products marketed and prescribed for HIV in Germany, including trade name, molecule name, and company
- HIV Product Sales: Find out the sales revenues of HIV products, both branded and generics, in Germany
- HIV Market Valuations: Find out the market size for HIV products in 2015 in Germany. Find out how the market advanced from 2010 and forecast to 2020
- HIV Products Market Share: Find out the market shares for key HIV products in Germany

Benefits of this Research:
The research helps executives to
- Support monitoring and reporting national HIV market analysis and sales trends
- Track competitor drugs sales and market share in Germany HIV market
- Track competitive developments in HIV market and present key issues and learnings
- Synthesize insights for HIV market and products to drive business performance
- Answer key business questions about the HIV market
- Evaluate commercial market opportunity assessment, positioning, and segmentation for HIV products
- Supports decision making in R&D to long term marketing strategies